 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

StockNews.com began coverage on shares of Applied Genetic Technologies (NASDAQ:AGTC Get Rating) in a research note published on Monday. The firm issued a sell rating on the biotechnology companys stock. AGTC has been the topic of several other reports. HC Wainwright cut Applied Genetic Technologies ...

Applied Genetic Technologies (NASDAQ:AGTC) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Applied Genetic Technologies (NASDAQ:AGTC  Get Rating) in a research note published on Monday. The firm issued a sell rating on the biotechnology companys stock. AGTC has been the topic of several other reports. HC Wainwright cut Applied ...

Applied Genetic Technologies Co. (NASDAQ:AGTC  Get Rating) saw a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 1,380,000 shares, a drop of 34.3% from the October 31st total of 2,100,000 shares. Based on an average trading volume...

Applied Genetic Technologies Co. (NASDAQ:AGTC) Sees Large Decrease in Short Interest

Shares of Applied Genetic Technologies Co. (NASDAQ:AGTC  Get Rating) have received an average recommendation of Hold from the nine brokerages that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have...

Applied Genetic Technologies Co. (NASDAQ:AGTC) Given Average Rating of "Hold" by Brokerages

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (AGTC or the Company) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (Syncona) has extended the expiration of its previously announced tender ...

Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation

StockNews.com began coverage on shares of Applied Genetic Technologies (NASDAQ:AGTC  Get Rating) in a report issued on Sunday. The firm issued a sell rating on the biotechnology companys stock. A number of other analysts have also recently issued reports on the company. Chardan Capital...

Applied Genetic Technologies (NASDAQ:AGTC) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Applied Genetic Technologies (NASDAQ:AGTC Get Rating) in a report issued on Sunday. The firm issued a sell rating on the biotechnology companys stock. A number of other analysts have also recently issued reports on the company. Chardan Capital cut Applied ...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all ...

*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*

Applied Genetic Technologies Co. (NASDAQ:AGTC  Get Rating)  Equities research analysts at Wedbush dropped their Q2 2023 earnings per share estimates for shares of Applied Genetic Technologies in a research note issued on Tuesday, November 22nd. Wedbush analyst D. Nierengarten now ...

Q2 2023 EPS Estimates for Applied Genetic Technologies Co. Decreased by Wedbush (NASDAQ:AGTC)

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all ...

*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*

Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.

Watchers	10,727
52-Wk Low	$0.2303
52-Wk High	$2.83

Market Cap	$26.64M
Volume (M)	764,531.00
52-Wk High	$2.83
52-Wk Low	$0.2303

AGTC Applied Genetic Technologies Corp

About

Feed

News

Fundamentals